- Clinical Trials
- April 2025
- 60 Pages
Global
From €1115EUR$1,250USD£956GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1115EUR$1,250USD£956GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1784EUR$2,000USD£1,530GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1784EUR$2,000USD£1,530GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Report
- June 2025
- 200 Pages
Global
From €2488EUR$2,789USD£2,134GBP
- Report
- July 2025
- 350 Pages
Global
From €4414EUR$4,949USD£3,786GBP
- Report
- July 2024
- 162 Pages
Africa
From €2230EUR$2,500USD£1,913GBP
- Report
- July 2024
- 164 Pages
Global
From €2230EUR$2,500USD£1,913GBP
- Report
- May 2024
- 134 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- December 2023
- 221 Pages
Global
From €3210EUR$3,599USD£2,753GBP
- Report
- May 2025
- 134 Pages
Global
From €16051EUR$17,995USD£13,767GBP
- Report
- December 2024
- 59 Pages
Global
From €3563EUR$3,995USD£3,056GBP
- Report
- August 2026
- 160 Pages
From €2961EUR$3,320USD£2,540GBP
€3702EUR$4,150USD£3,175GBP
- Report
- August 2026
- 160 Pages
From €2961EUR$3,320USD£2,540GBP
€3702EUR$4,150USD£3,175GBP
- Report
- August 2025
- 150 Pages
Global
From €2819EUR$3,160USD£2,417GBP
€3523EUR$3,950USD£3,022GBP
- Report
- July 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,710GBP
- Report
- March 2024
- 95 Pages
Europe
From €1338EUR$1,500USD£1,148GBP
- Report
- March 2024
- 97 Pages
Asia Pacific
From €1338EUR$1,500USD£1,148GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more